on BASTIDE (EPA:BLC)
Groupe Bastide Announces Sale of EXPERF to Sapio Group
On May 21, 2026, Groupe Bastide confirmed the sale of its subsidiary New Medical Concept, the holding company of EXPERF, to Sapio Group. EXPERF specializes in home infusion and clinical nutrition care. Acquired in 2017, EXPERF has experienced robust growth, doubling its revenue to €42 million and expanding to 28 locations by 2025. The transaction aligns with Bastide's strategy, enhancing its financial structure by reducing leverage.
Expected deconsolidation implies no significant impact on Bastide's 2026 financial year revenue, holding the forecast at €510 million. The move supports Bastide's focus on optimizing asset value and reducing debt, anticipating a financial leverage above 2.5x post-transaction. Completion awaits standard closing conditions.
Sapio Group views this acquisition as a strategic advancement in the European healthcare market, enhancing its operations in France. Bastide and Sapio were respectively advised by Oddo BHF and Goodwin Procter LLP.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BASTIDE news